GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Novanta Inc (NAS:NOVT) » Definitions » Cash, Cash Equivalents, Marketable Securities

Novanta (Novanta) Cash, Cash Equivalents, Marketable Securities : $93.5 Mil (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Novanta Cash, Cash Equivalents, Marketable Securities?

Novanta's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 ($75.96 Mil) to Dec. 2023 ($105.05 Mil) but then stayed the same from Dec. 2023 ($105.05 Mil) to Mar. 2024 ($93.52 Mil).

Novanta's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($117.39 Mil) to Dec. 2022 ($100.11 Mil) but then increased from Dec. 2022 ($100.11 Mil) to Dec. 2023 ($105.05 Mil).


Novanta Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Novanta's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novanta Cash, Cash Equivalents, Marketable Securities Chart

Novanta Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.94 125.05 117.39 100.11 105.05

Novanta Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.68 91.33 75.96 105.05 93.52

Novanta Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Novanta  (NAS:NOVT) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Novanta Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Novanta's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Novanta (Novanta) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Novanta Inc (NAS:NOVT) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: photonics, vision, and precision motion. The photonics segment, which sells photonics-based products that include carbon dioxide lasers, laser scanning, super-resolution imaging lasers, and laser beam delivery items. The vision segment sells medical-grade technologies, including visualization solutions, imaging informatics products, and thermal printers contributing the majority of revenue. The precision motion segment sells optical encoders, motion control technology, and precision machined components. The firm generates the majority of its revenue from the United States and Europe.
Executives
Robert Buckley officer: Chief Financial Officer C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Matthijs Glastra officer: Group President,Laser Products C/O GSI GROUP CORPORATION, 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Brian S Young officer: Executive VP, Human Resources C/O 25 CORPORATE DRIVE, BURLINGTON MA 01803
Thomas N Secor director GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Barbara B. Hulit director C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Michele Davis Welsh officer: General Counsel C/O NOVANTA INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Solomon Darlene J. S. director 6070 PARKLAND BLVD., MAYFIELD HTS. OH 44124
Peter L Chang officer: Vice President-Corp Controller C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Frank Anders Wilson director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Katherine Ann Owen director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Maxine Lum Mauricio director 301 MERRITT SEVEN CORPORATE PARK, 6TH FL, C/O EMCOR GROUP INC., NORWALK CT 06851
Stephen W Bershad director 66 ARROYO HONDO TRAIL, SANTA FE NM 87508
Deborah Disanzo director 7601 PENN AVENUE SOUTH, RICHFIELD MN 55423
Lonny J Carpenter director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Brian Douglas King director C/O NOVANTA INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730